CONBRIZA

देश: इसराइल

भाषा: अंग्रेज़ी

स्रोत: Ministry of Health

सक्रिय संघटक:

BAZEDOXIFENE AS ACETATE 20 MG

थमां उपलब्ध:

NEOPHARM LTD

ए.टी.सी कोड:

G03XC02

फार्मास्यूटिकल फॉर्म:

COATED TABLETS

प्रशासन का मार्ग:

PER OS

द्वारा बनाया गया:

PFIZER IRELAND PHARMACEUTICALS

चिकित्सीय समूह:

BAZEDOXIFENE

चिकित्सीय संकेत:

CONBRIZA is indicated for the treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of vertebral fractures has been demonstrated; efficacy on hip fractures has not been established. When determining the choice of CONBRIZA or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefit

प्राधिकरण की तारीख:

2013-04-01